🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
BAROPHARM Co., Ltd. (KOSDAQ:0153R0)
South Korea flag South Korea · Delayed Price · Currency is KRW
6,700.00
-610.00 (-8.34%)
At close: Nov 17, 2026

BAROPHARM Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23
Operating Revenue
145,03096,72445,53811,591
Other Revenue
0--0-0
145,03096,72445,53811,591
Revenue Growth
-112.40%292.88%-
Cost of Revenue
119,65381,15134,3744,668
Gross Profit
25,37715,57311,1646,923
Selling, General & Admin
20,97118,49215,7938,920
Amortization of Goodwill & Intangibles
51.4739.9628.4530.27
Other Operating Expenses
292.5190.42168.3129.3
Operating Expenses
22,11319,50516,6159,422
Operating Income
3,263-3,932-5,451-2,499
Interest Expense
-483.12-73.81-58.76-91.63
Interest & Investment Income
566.41541.29561.58423.19
Other Non Operating Income (Expenses)
-1,757-6,211-12,426-4,939
EBT Excluding Unusual Items
1,589-9,675-17,374-7,107
Gain (Loss) on Sale of Assets
13.1121.91-1.55-
Pretax Income
1,602-9,653-17,376-7,107
Income Tax Expense
98.8625.98145.92-
Net Income
1,504-9,679-17,522-7,107
Net Income to Common
1,504-9,679-17,522-7,107
Net Income Growth
----
Shares Outstanding (Basic)
9766
Shares Outstanding (Diluted)
9766
Shares Change
-6.02%0.31%-
EPS (Basic)
161.70-1461.38-2804.61-1141.00
EPS (Diluted)
159.45-1461.38-2804.61-1141.00
EPS Growth
----

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23
Free Cash Flow
-19,193-26,127-2,560-5,902
Free Cash Flow Per Share
-2035.36-3944.59-409.69-947.69
Gross Margin
17.50%16.10%24.52%59.73%
Operating Margin
2.25%-4.06%-11.97%-21.56%
Profit Margin
1.04%-10.01%-38.48%-61.31%
Free Cash Flow Margin
-13.23%-27.01%-5.62%-50.92%
EBITDA
4,179-3,088-4,798-2,126
EBITDA Margin
2.88%-3.19%-10.54%-18.34%
D&A For EBITDA
915.89843.38652.96373.05
EBIT
3,263-3,932-5,451-2,499
EBIT Margin
2.25%-4.06%-11.97%-21.56%
Advertising Expenses
-2,3971,204932.01